MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5551/jat.6023

Медицинская библиотека · Journal of atherosclerosis and thrombosis · 2010

Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention.

Momiyama Yukihiko, Ohmori Reiko, Uto-Kondo Harumi, Tanaka Nobukiyo, Kato Ryuichi, Taniguchi Hiroaki, Arakawa Koh, Nakamura Haruo, Ohsuzu Fumitaka

СтатьяПеревод пока не подготовлен

Аннотация

AIM: Resistin is an adipocytokine that may link inflammation and atherosclerosis.We studied the associations of resistin levels with cardiovascular events and restenosis.

METHODS

We measured pre-procedural serum resistin levels in 140 patients with coronary artery disease undergoing elective percutaneous coronary intervention (PCI), of whom 97 had a stent. Restenosis was defined as > 50% stenosis at follow-up angiography. Patients were followed for 3 years for major adverse cardiovascular events (MACE).

RESULTS

At 8±6 months after PCI, reangiography was performed in 94 (67%) patients, of whom 42 had restenosis. Between 42 patients with restenosis and 52 without restenosis, resistin (4.5±2.6 vs. 4.5±2.5 ng/mL) and Creactive protein (CRP) (median 0.70 vs. 0.70 mg/L) levels did not differ. During 3-year follow-up, MACE occurred in 24 patients (1 death, 21 unstable angina, 2 stroke). Compared with 116 patients without MACE, 24 with MACE had higher resistin (5.4±2.4 vs. 4.3±2.5 ng/mL) and CRP (1.30 vs. 0.60 mg/L) levels (p< 0.05). Patients with MACE more often had resistin >4.0 ng/mL than without MACE (75% vs. 35%, p< 0.001). Resistin correlated with CRP levels (r= 0.31). To clarify the association between MACE and resistin, patients were divided into 2 groups by resistin levels. Kaplan-Meier analysis showed a lower event-free survival rate in patients with resistin > 4.0 ng/mL than without it (p< 0.001). On multivariate analysis, resistin, but not CRP, was an independent predictor of MACE. The hazard ratio for MACE was 3.6 (95%CI=1.4-9.2) for resistin > 4.0 ng/mL.

CONCLUSION

Serum resistin levels were found to be associated with further cardiovascular events in patients undergoing PCI.

Для цитирования: Momiyama Yukihiko, Ohmori Reiko, Uto-Kondo Harumi, Tanaka Nobukiyo, Kato Ryuichi, Taniguchi Hiroaki, Arakawa Koh, Nakamura Haruo, Ohsuzu Fumitaka. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention.. Journal of atherosclerosis and thrombosis. 2010. DOI: 10.5551/jat.6023.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.